chr19-3585680-CG-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_133261.3(GIPC3):c.85del(p.Ala29ProfsTer68) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000617 in 1,361,678 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000040 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000064 ( 0 hom. )
Consequence
GIPC3
NM_133261.3 frameshift
NM_133261.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -3.00
Genes affected
GIPC3 (HGNC:18183): (GIPC PDZ domain containing family member 3) The protein encoded by this gene belongs to the GIPC family. Studies in mice suggest that this gene is required for postnatal maturation of the hair bundle and long-term survival of hair cells and spiral ganglion in the ear. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 28 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-3585680-CG-C is Pathogenic according to our data. Variant chr19-3585680-CG-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 3067408.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, Uncertain_significance=2}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GIPC3 | NM_133261.3 | c.85del | p.Ala29ProfsTer68 | frameshift_variant | 1/6 | ENST00000644452.3 | |
GIPC3 | NM_001411144.1 | c.85del | p.Ala29ProfsTer68 | frameshift_variant | 1/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GIPC3 | ENST00000644452.3 | c.85del | p.Ala29ProfsTer68 | frameshift_variant | 1/6 | NM_133261.3 | P1 | ||
GIPC3 | ENST00000644946.1 | c.85del | p.Ala29ProfsTer68 | frameshift_variant | 1/6 |
Frequencies
GnomAD3 genomes AF: 0.0000397 AC: 6AN: 151050Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
6
AN:
151050
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000272 AC: 2AN: 73508Hom.: 0 AF XY: 0.0000233 AC XY: 1AN XY: 42830
GnomAD3 exomes
AF:
AC:
2
AN:
73508
Hom.:
AF XY:
AC XY:
1
AN XY:
42830
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000644 AC: 78AN: 1210628Hom.: 0 Cov.: 31 AF XY: 0.0000657 AC XY: 39AN XY: 593260
GnomAD4 exome
AF:
AC:
78
AN:
1210628
Hom.:
Cov.:
31
AF XY:
AC XY:
39
AN XY:
593260
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000397 AC: 6AN: 151050Hom.: 0 Cov.: 31 AF XY: 0.0000543 AC XY: 4AN XY: 73722
GnomAD4 genome
AF:
AC:
6
AN:
151050
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
73722
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | GIPC3: PM2, PVS1:Moderate - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 08, 2023 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge - |
Rare genetic deafness Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 04, 2017 | The p.Ala29ProfsX68 variant in GIPC3 has not been previously reported in individuals with hearing loss and was present in 0.06% (1/1748) of European chromosomes studies by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs756840753). This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 29 and leads to a premature termination codon 68 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. In summary, although additional studies are required to fully establish its clinical significance, the p.Ala29ProfsX68 variant is likely pathogenic for autosomal recessive hearing loss based upon predicted impact and low allele frequency. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at